The Aftermath of COVID-19: Exploring the Long-Term Effects on Organ Systems
Overview
Authors
Affiliations
Background: Post-acute sequelae of SARS-CoV-2 infection (PASC) is a complicated disease that affects millions of people all over the world. Previous studies have shown that PASC impacts 10% of SARS-CoV-2 infected patients of which 50-70% are hospitalised. It has also been shown that 10-12% of those vaccinated against COVID-19 were affected by PASC and its complications. The severity and the later development of PASC symptoms are positively associated with the early intensity of the infection.
Results: The generated health complications caused by PASC involve a vast variety of organ systems. Patients affected by PASC have been diagnosed with neuropsychiatric and neurological symptoms. The cardiovascular system also has been involved and several diseases such as myocarditis, pericarditis, and coronary artery diseases were reported. Chronic hematological problems such as thrombotic endothelialitis and hypercoagulability were described as conditions that could increase the risk of clotting disorders and coagulopathy in PASC patients. Chest pain, breathlessness, and cough in PASC patients were associated with the respiratory system in long-COVID causing respiratory distress syndrome. The observed immune complications were notable, involving several diseases. The renal system also was impacted, which resulted in raising the risk of diseases such as thrombotic issues, fibrosis, and sepsis. Endocrine gland malfunction can lead to diabetes, thyroiditis, and male infertility. Symptoms such as diarrhea, nausea, loss of appetite, and taste were also among reported observations due to several gastrointestinal disorders. Skin abnormalities might be an indication of infection and long-term implications such as persistent cutaneous complaints linked to PASC.
Conclusions: Long-COVID is a multidimensional syndrome with considerable public health implications, affecting several physiological systems and demanding thorough medical therapy, and more study to address its underlying causes and long-term effects is needed.
Exploring Asthma as a Protective Factor in COVID-19 Outcomes.
Quinn A, Zhao L, Bell S, Huq M, Fang Y Int J Mol Sci. 2025; 26(4).
PMID: 40004141 PMC: 11855143. DOI: 10.3390/ijms26041678.
Yi J, Liu Z, Cao X, Pi L, Zhou C, Mu H Front Cell Infect Microbiol. 2024; 14:1477585.
PMID: 39717543 PMC: 11663740. DOI: 10.3389/fcimb.2024.1477585.
Valea A, Costachescu M, Stanciu M, Nistor C, Sima O, Carsote M Life (Basel). 2024; 14(11).
PMID: 39598179 PMC: 11595665. DOI: 10.3390/life14111380.
Long-Term Impacts of COVID-19 on Thyroid Health: Insights From Clinical Studies.
Syal R, Kaur J, Siddiqui M, Amatul-Raheem H, Suarez C, Bojanki N Cureus. 2024; 16(10):e71469.
PMID: 39544551 PMC: 11560388. DOI: 10.7759/cureus.71469.
COVID-19: a multi-organ perspective.
Guarienti F, Goncalves J, Budelon Goncalves J, Xavier F, Marinowic D, Machado D Front Cell Infect Microbiol. 2024; 14:1425547.
PMID: 39492990 PMC: 11527788. DOI: 10.3389/fcimb.2024.1425547.